CSX
57
-4
AXP
67
-2
HPE
44
-2
APH
65
-3
MAS
52
-4
ISRG
71
-5
D
40
2
SWK
50
-5
UAL
83
-2
BA
47
2
TDC
67
-4
LH
40
-5
GILD
47
-8
SCHW
62
-2
FTI
71
-7
BDX
56
10
RCL
83
-2
NOV
52
-5
ROP
53
-9
AIV
64
4
CSX
57
-4
AXP
67
-2
HPE
44
-2
APH
65
-3
MAS
52
-4
ISRG
71
-5
D
40
2
SWK
50
-5
UAL
83
-2
BA
47
2
TDC
67
-4
LH
40
-5
GILD
47
-8
SCHW
62
-2
FTI
71
-7
BDX
56
10
RCL
83
-2
NOV
52
-5
ROP
53
-9
AIV
64
4
Financhill
Back

First Citizens BancShares Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
60

FCNCA
First Citizens BancShares

Last Price:
2,200.79
Seasonality Move:
4.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
60
First Citizens BancShares (FCNCA) is a Buy

Is First Citizens BancShares a Buy, Sell or Hold?

  • The current First Citizens BancShares [FCNCA] share price is $2,200.46. The Score for FCNCA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • FCNCA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCNCA Stock Price Chart

What is First Citizens BancShares's stock price today?

  • The First Citizens BancShares share price today is $2,200.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCNCA is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FCNCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 61.21 Buy
Relative Strength Index (14 RSI): 62.28 Buy
Chaikin Money Flow: 54615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1936.68 - 2163.94) Buy
Bollinger Bands (100): (1805.61 - 2068.87) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FCNCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2186.78 Buy
20-day SMA: 2050.61 Buy
50-day SMA: 1969.75 Buy
200-day SMA: 1779.64 Buy
8-day EMA: 2147.77 Buy
20-day EMA: 2079.96 Buy
50-day EMA: 2006.44 Buy
200-day EMA: 1795.61 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Citizens BancShares Earnings Growth & FCNCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $6.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.27 per share, and a decrease next year of $25.86 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Citizens BancShares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):